New Weight Loss Drug Retatrutide Delivers Stunning Results


  • David Letterman Talks Racing Passion, Heart Scare, Late Night TV

    03:34

  • Get the Most out of Your Annual Physical With These Tips

    04:21

  • Surgeon General Issues Suggested Screen Time Limits for Kids

    04:27

  • David Letterman Talks End of ‘Late Show,’ Indy500, Heart Health

    05:22

  • New Mexico Hazmat Emergency Leaves 3 Dead

    00:31

  • Now Playing

    New Weight Loss Drug Retatrutide Delivers Stunning Results

    03:13

  • UP NEXT

    Detroit-Bound Plane Diverted to Canada Over Ebola Concerns

    02:00

  • Olympic Gold Medalists Give Lesson in Swim Safety Ahead of Summer

    04:20

  • What Are the Benefits of Adding Peptides to Your Daily Routine?

    04:50

  • Health Officials Race to Trace Rising Ebola Cases in Central Africa

    02:07

  • How to Navigate a Break-Up With a Friend

    04:10

  • How Women Can Prioritize Health — and What to Check Annually

    05:09

  • What is ‘Ozempic Personality’? How GLP-1s Can Affect Mood

    05:26

  • American Doctor Infected With Ebola While Working in Congo

    01:20

  • Straus Family Creamery Ice Cream Recalled for Metal Fragments

    00:28

  • How to Encourage Mental Health Conversations With Your Teen

    06:05

  • Tips for Understanding and Managing Your Blood Pressure

    04:55

  • Ebola Outbreak in Congo and Uganda Declared Global Emergency

    00:31

  • Hantavirus Cruise Ship Arrives in Netherlands to Be Disinfected

    02:08

  • Dr. Edith Eger, Holocaust Survivor and Psychologist, Dies at 98

    02:19

Remarkable new test results by drugmaker Eli Lilly reveal that their latest weight loss drug, retatrutide, may be even more effective than the three popular GLP-1s currently available. The new drug is designed to mimic three hormones responsible for hunger regulation and fat burning. NBC’s medical contributor Dr. Natalie Azar breaks down the trial results and discusses how soon the new drug is likely to get FDA approval.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *